Progyny, Inc.
Financials
Valuation Metrics
Progyny, Inc.'s Market Cap is $2.47B. At end of 2025 it was $2.19B. Ranked #1911 of 3,112 in US market (top 61%), #708 of 1,445 on NASDAQ (top 49%), #111 of 206 in Health Care Equipment & Services (top 54%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.47B | US#1,911/3,112 Sec#111/206 |
| Revenue | $1.29B | US#1,777/3,112 Sec#110/206 |
| Net Income | $68M | US#1,751/3,112 Sec#85/206 |
| Total Assets | $698M | US#2,603/3,112 Sec#143/206 |
| Net Assets | $439M | US#2,345/3,112 Sec#124/206 |
| Employees | 835 | US#1,285/3,112 Sec#105/206 |
| Value | ||
| P/E | 36.49x | US#1,631/3,112 Sec#71/206 |
| P/B | 5.62x | US#2,265/3,112 Sec#147/206 |
| PEG | 0.60x | US#636/3,112 Sec#21/206 |
| P/S | 1.91x | US#1,217/3,112 Sec#87/206 |
| EV/EBITDA | 21.28x | US#1,919/3,112 Sec#90/206 |
| FCF Yield | 7.47% | US#802/3,112 Sec#32/206 |
| Profitability | ||
| ROE | 15.41% | US#845/3,112 Sec#38/206 |
| ROA | 9.69% | US#478/3,112 Sec#31/206 |
| Op. Margin | 7.46% | US#1,847/3,112 Sec#92/206 |
| Revenue Growth | 1.38% | US#2,110/3,112 Sec#161/206 |
| Earnings Growth | 60.91% | US#497/3,112 Sec#19/206 |
| Financial Health | ||
| Debt Ratio | 58.95% | US#663/3,112 Sec#77/206 |
| Total Debt | $27M | US#2,658/3,112 Sec#167/206 |
| FCF | $184M | US#1,394/3,112 Sec#84/206 |
| Cash | $133M | US#2,026/3,112 Sec#128/206 |
| Current Ratio | 2.13x | US#1,167/3,112 Sec#107/206 |
| Net Debt/EBITDA | -0.95x | US#318/3,112 Sec#21/206 |
| Performance | ||
| 1Y Return | 40.20% | US#1,027/3,112 Sec#66/206 |
| 1M Return | 4.33% | US#1,030/3,112 Sec#81/206 |
| From 52W High | -4.66% | US#527/3,112 Sec#37/206 |
| 1Y MDD | -42.65% | US#2,082/3,112 Sec#117/206 |
| Trading | ||
| Volume | 881,237 shares | US#1,587/3,112 Sec#114/206 |
| Trading Value | $28M | US#1,779/3,112 Sec#119/206 |
| Per Share | ||
| EPS | $0.69 | US#1,754/3,112 Sec#91/206 |
| BPS | $6.05 | US#2,123/3,112 Sec#134/206 |
Company Info
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.